Overexpression of Akt-1 gene in human hepatocellular carcinoma

Chinese Journal of Cancer Research

Volumn 14, Issue 3, 2002, Pages 161-164

  Liu, Lian Xin ^a,b   Liu, Zhi Hua ^b   Jiang, Hong Chi ^a   Qi, Shu Yi ^a   Zhang, Wei Hui ^a   Zhu, An Long ^a   Wang, Xiu Qin ^b   Wu, Min ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b CANCER HOSPITAL   (China)

Author keywords

Hepatocellular carcinoma (HCC); Northern blot; Protein kinase B Akt (Akt 1); Reverse transcription polymerase chain reaction (RT PCR)

Indexed keywords

PROTEIN KINASE B;

ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; NORTHERN BLOTTING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION;

EID: 0036743543     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11670-002-0036-1     Document Type: Article

References (26)

1. Tang ZY. Hepatocellular carcinoma-Cause, treatment and metastasis [J]. World J Gastroenterol 2001; 7:445.
2. Schafer DF, Sorrell MF. Hepatocellular carcinoma [J]. Lancet 1999; 353:1253.
3. Hanley AJ, Choi BC, Holoway EJ. Cancer mortality among Chinese migrants: a review [J]. Int J Epidemiol 1995; 24:255.
4. Naka T, Toyota N, Kaneko T, et al. Protein expression of p53, p21 WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma [J]. Anticancer Res 1998; 18:555.
5. Montesano R, Hainaut P, Wild CP. Hepatocellular carcinoma: from gene to public health [J]. J Natl Cancer Inst 1997; 89:1844.
6. Collier JD, Guo K, Gullick WJ, et al. Expression of transforming growth factor alpha in human hepatocellular carcinoma [J]. Liver 1993; 13:151.
7. Chung DC. The genetic basis of colorectal cancer: Insights into critical pathways of tumorigenesis [J]. Gastroenterology 2000; 119:854.
8. Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts [J]. Genes Dev 1999; 13:2905.
9. Roy HK, Olusola BF, Clemens DL, et al. AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis [J]. Carcinogenesis 2002; 23:201.
10. Ringel MD, Hayre N, Saito J, et al. Overexpression and overactivation of Akt in thyroid carcinoma [J]. Cancer Res 2001; 61:6105.
11. Cantley LC, Neel BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway [J]. Proc Natl Acad Sci USA 1999; 96:4240.
12. Downward J. Mechanisms and consequences of activation of protein kinase B/Akt [J]. Curr Opin Cell Biol 1998; 10:262.
13. Alessi DR, Cohen P. Mechanism of activation and function of protein kinase B [J]. Curr Opin Genet Dev 1998; 8:55.
14. Coffer PJ, Jin J, Woodgett JR. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation [J]. Biochem J 1998; 335:1.
15. Nakatani K, Sakaue H, Thompson DA, et al. Identification of a human Akt3 (protein kinase B gamma) which contains the regulatory serine phosphorylation site [J]. Biochem Biophys Res Commun 1999; 257:906.
16. Cheng JQ, Godwin AK, Bellacosa A, et al. AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas [J]. Proc Natl Acad Sci USA 1992; 89:9267.
17. Masure S, Haefner B, Wesselink JJ, et al. Molecular cloning, expression and characterization of the human serine/threonine kinase Akt-3 [J]. Eur J Biochem 1999; 265:353.
18. Brazil DP, Hemmings BA. Ten years of protein kinase B signalling: a hard Akt to follow [J]. Trends Biochem Sci 2001; 26:657.
19. Staal SP. Molecular cloning of the Akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma [J]. Proc Natl Acad Sci USA 1987; 84:5034.
20. Bellacosa A, de Feo D, Godwin AK, et al. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas [J]. Int J Cancer 1995; 64:280.
21. Cheng JQ, Altomare DA, Klein MA, et al. Transforming activity and mitosis-related expression of the AKT2 oncogene: evidence suggesting a link between cell cycle regulation and oncogenesis [J]. Oncogene 1997; 14:2793.
22. Ruggeri BA, Huang L, Wood M, et al. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas [J]. Mol Carcinog 1998; 21:81.
23. Nakatani K, Thompson DA, Barthel A, et al. Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines [J]. J Biol Chem 1999; 274:21528.
24. Zinda MJ, Johnson MA, Paul JD, et al. AKT-1, -2, and -3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon [J]. Clin Cancer Res 2001; 7:2475.
25. De Vita G, Berlingieri MT, Visconti R, et al. Akt/protein kinase B promotes survival and hormone-independent proliferation of thyroid cells in the absence of dedifferentiating and transforming effects [J]. Cancer Res 2000; 60:3916.
26. Saito J, Kohn AD, Roth RA, et al. Regulation of FRTL-5 thyroid cell growth by phosphatidylinositol (OH) 3 kinase-dependent Akt-mediated signaling [J]. Thyroid 2001; 11:339.